| #341 |
Chiaki Osaka |
Mercari |
5 |
| #341 |
Mason Martinez |
— |
5 |
| #341 |
Lisa Friedman |
Reg Life Sciences |
5 |
| #341 |
Erik Huntzicker |
Genentech |
5 |
| #341 |
Charles Hart |
Threshold Pharmaceuticals |
5 |
| #341 |
Matthew J. Geiger |
— |
5 |
| #341 |
Paul M. Moran |
Genentech |
5 |
| #341 |
Ryan Pandya |
Perfect Day |
5 |
| #341 |
Aaron L. Kurtzman |
I2 Pharmaceuticals |
5 |
| #341 |
Jennifer Kuo Chen Huang |
Cytokinetics |
5 |
| #341 |
Mayumi N. Bowen |
Genentech |
5 |
| #341 |
Brian Boomgaard |
Zipline International |
5 |
| #341 |
Arlyn Arcalas |
Exelixis |
5 |
| #341 |
Anas Lasram |
Zoox |
5 |
| #341 |
Jan-Willem Theunissen |
Pierre Fabre Médicament |
5 |
| #341 |
Jonathan K. Lassila |
Danisco Us |
5 |
| #341 |
Monique Relova |
Humane |
5 |
| #341 |
Hans Purkey |
Genentech |
5 |
| #341 |
Jill Fredrickson |
Genentech |
5 |
| #341 |
Ruperto G Mariano |
Dioxycle |
5 |
| #341 |
Paul Scott Eastman |
Laboratory Corporation Of America Holdings |
5 |
| #341 |
Prasenjit Kumar Mukherjee |
Gilead Sciences |
5 |
| #341 |
Steve Coffin |
Kinestral Technologies |
5 |
| #341 |
Mohammad Al-Sayah |
Genentech |
5 |
| #341 |
Debarshi Basu |
Texas Instruments |
5 |
| #341 |
Piotr Robert Slawinski |
Noah Medical |
5 |
| #341 |
Harini KALUARACHCHI |
Genentech |
5 |
| #341 |
Cameron NOLAND |
Genentech |
5 |
| #341 |
Whitney Shatz |
Genentech |
5 |
| #341 |
Courtney Beers |
Amgen |
5 |
| #341 |
Gaik Wei Tew |
Genentech |
5 |
| #341 |
Mary Keir |
Genentech |
5 |
| #341 |
Mircea Manea |
— |
5 |
| #341 |
Roel Funke |
Exelixis |
5 |
| #341 |
Tyler Jon Daniel |
Sony |
5 |
| #341 |
Ganesh A. Kolumam |
Genentech |
5 |
| #341 |
Eddie Sirhan |
— |
5 |
| #341 |
Hong-Bing Shu |
National Jewish Health |
5 |
| #341 |
Bradley M. Bond |
Emerald Therapeutics |
5 |
| #341 |
Yuri Pudgorodsky |
Swsoft Holdings |
5 |
| #341 |
Wenlu Li |
Diadexus |
5 |
| #341 |
Nicholas Scott Reimnitz |
Bellwether Coffee |
5 |
| #341 |
Doug Brainard |
Kinestral Technologies |
5 |
| #341 |
Ohseung Kwon |
Dexcom |
5 |
| #341 |
Jeffrey Wallin |
Genentech |
5 |
| #341 |
Bradley Paul Morgan |
Cytokinetics |
5 |
| #341 |
Stephen Lau |
Exelixis |
5 |
| #341 |
Stanley J. Hollenbach |
Millennium Pharmaceuticals |
5 |
| #341 |
Robert A. Blake |
Genentech |
5 |
| #400 |
Vincent DiMassa |
Amgen |
4 |